Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01596231 · ClinicalTrials.gov registry record · Phase 2
Kudzu Treatment for Alcohol Abuse
A Phase 2 study, sponsored by Mclean Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT01596231 is a Phase 2 study that has completed, run by Mclean Hospital. The registered enrollment target is 20 participants.
The verdict
NCT01596231, a Phase 2 study, has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a study designed to test whether a single administration of kudzu extract (2 mg) will significantly reduce the number of drinks consumed during a single 1 ½ hours drinking session when given as pretreatment 2 ½ hours before the drinking session.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Kudzu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-05 |
| Est. Completion | 2014-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01596231
The ClinicalTrials.gov registry entry for NCT01596231 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01596231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01596231 about?
NCT01596231 is a clinical study titled "Kudzu Treatment for Alcohol Abuse". This is a study designed to test whether a single administration of kudzu extract (2 mg) will significantly reduce the number of drinks consumed during a single 1 ½ hours drinking session when given as pretreatment 2 ½ hours before the drinking session.
What is the current status of trial NCT01596231?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2010-05. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01596231?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Kudzu (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01596231?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.